Pharmaceutical Compositions for Intranasal Administration for the Treatment of Neurodegenerative Disorders
First Claim
1. A pharmaceutical composition for intranasal administration, comprising an effective amount of insulin, dimethyl sulfoxide, and a pharmaceutically acceptable excipient.
1 Assignment
0 Petitions
Accused Products
Abstract
In one embodiment of the invention, a pharmaceutical composition for intranasal administration comprises insulin, dimethyl sulfoxide and at least one pharmaceutically acceptable excipient. In another embodiment of the invention, a pharmaceutical composition for intranasal administration comprises clioquinol, dimethyl sulfoxide and at least one pharmaceutically acceptable excipient. In yet another embodiment of the invention, a pharmaceutical composition for intranasal administration comprises insulin, clioquinol, dimethyl sulfoxide and at least one pharmaceutically acceptable excipient. The pharmaceutical compositions of the invention may be used to treat or prevent a neurodegenerative disorder such as Alzheimer'"'"'s disease, stroke, Parkinson'"'"'s disease, multiple sclerosis, spinal cord injuries, and/or traumatic brain injuries and the like, in addition to other systemic and local diseases.
-
Citations
18 Claims
- 1. A pharmaceutical composition for intranasal administration, comprising an effective amount of insulin, dimethyl sulfoxide, and a pharmaceutically acceptable excipient.
- 7. A pharmaceutical composition for intranasal administration, comprising an effective amount of clioquinol, dimethyl sulfoxide, and a pharmaceutically acceptable excipient.
- 13. A pharmaceutical composition for intranasal administration, comprising an effective amount of insulin, clioquinol, dimethyl sulfoxide, and a pharmaceutically acceptable excipient.
Specification